The study tested how commercially-available cannabis products affect the experiences of exercising.
A study conducted by researchers at the University of Colorado, Boulder and the University of Colorado, Anschutz Medical Campus explored the effects of cannabis on exercise (1). The study, “Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study,” was published in December 2023 in the journal Sports Medicine and is reportedly the first of its kind in this subject area (1). In 2013, Colorado became the first state in the nation to begin legal recreational cannabis sales (2).
This study collected data and asked questions of 42 runners—who were also regular cannabis users—while exercising first without cannabis and after consuming a cannabis flower product, either a Δ9 tetrahydrocannabinol (THC) dominant or cannabidiol (CBD) dominant product (1). After their baseline measurements were taken, the volunteer participants ran for 30 minutes on a treadmill, then in a separate session repeated the activity after consuming cannabis (1). Both positive and negative effects were reported (1). The participants described a more positive exercise experience and runner’s high symptoms when exercising after consuming cannabis, particularly in the CBD group, but those in the THC group said running was noticeably more difficult (1,2). “The bottom-line finding is that cannabis before exercise seems to increase positive mood and enjoyment during exercise, whether you use THC or CBD. But THC products specifically may make exercise feel more effortful,” explained lead study author Laurel Gibson in CU Boulder Today (2).
In the abstract, the authors noted the common concern of the potential sedentary effects of cannabis combined with national increases in cannabis use in the nation (1). However, the authors also hypothesized that cannabis could help give a boost to people who struggle to exercise (2). “We have an epidemic of sedentary lifestyle in this country, and we need new tools to try to get people to move their bodies in ways that are enjoyable,” stated study author Angela Bryan (2). “If cannabis is one of those tools, we need to explore it, keeping in mind both the harms and the benefits.” One of the goals of the study in general was to provide health care providers and policymakers data to make more informed decisions, stated Gibson in an interview (2).
Hear one of our Noid Knowledge podcast guests, Steve Ellmore, describe his experience with cannabis and running in our Noid Factoid.
References
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.